Publications
Export 39 results:
Filters: Author is Isabelle St-Amour [Clear All Filters]
“Differential Regulation of Tau Exon 2 and 10 Isoforms in Huntington's Disease Brain.”, Neuroscience, 2022.
, “Widespread alterations in microRNA biogenesis in human Huntington's disease putamen.”, Acta Neuropathol Commun, vol. 10, no. 1, p. 106, 2022.
, ,
“Advances and Challenges in Understanding MicroRNA Function in Tauopathies: A Case Study of miR-132/212.”, Front Neurol, vol. 11, p. 578720, 2020.
, “Retinal function anomalies in young offspring at genetic risk of schizophrenia and mood disorder: The meaning for the illness pathophysiology.”, Schizophr Res, vol. 219, pp. 19-24, 2020.
, “Peripheral adaptive immunity of the triple transgenic mouse model of Alzheimer's disease.”, J Neuroinflammation, vol. 16, no. 1, p. 3, 2019.
, “Platelet abnormalities in Huntington's disease.”, J Neurol Neurosurg Psychiatry, vol. 90, no. 3, pp. 272-283, 2019.
, “Portrait of blood-derived extracellular vesicles in patients with Parkinson's disease.”, Neurobiol Dis, vol. 124, pp. 163-175, 2019.
, “Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background.”, Synapse, vol. 72, no. 4, 2018.
, “Co-occurrence of mixed proteinopathies in late-stage Huntington's disease.”, Acta Neuropathol, vol. 135, no. 2, pp. 249-265, 2018.
, “Huntingtin Aggregation Impairs Autophagy, Leading to Argonaute-2 Accumulation and Global MicroRNA Dysregulation.”, Cell Rep, vol. 24, no. 6, pp. 1397-1406, 2018.
, “Platelet-derived extracellular vesicles in Huntington's disease.”, J Neurol, vol. 265, no. 11, pp. 2704-2712, 2018.
, “Immunotherapies in Alzheimer's disease: Too much, too little, too late or off-target?”, Acta Neuropathol, vol. 131, no. 4, pp. 481-504, 2016.
, “Impaired thermoregulation and beneficial effects of thermoneutrality in the 3×Tg-AD model of Alzheimer's disease.”, Neurobiol Aging, vol. 43, pp. 47-57, 2016.
, “Partial neurorescue effects of DHA following a 6-OHDA lesion of the mouse dopaminergic system.”, J Nutr Biochem, vol. 30, pp. 133-42, 2016.
, “Age-dependent impairment of glucose tolerance in the 3xTg-AD mouse model of Alzheimer's disease.”, FASEB J, vol. 29, no. 10, pp. 4273-84, 2015.
, “Cerebrovascular and blood-brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology.”, Ann Neurol, vol. 78, no. 2, pp. 160-77, 2015.
, “Human apolipoprotein E ɛ4 expression impairs cerebral vascularization and blood-brain barrier function in mice.”, J Cereb Blood Flow Metab, vol. 35, no. 1, pp. 86-94, 2015.
, “Targeting cerebrovascular impairments in Huntington's disease: a novel treatment perspective.”, Neurodegener Dis Manag, vol. 5, no. 5, pp. 389-93, 2015.
, “The different effects of LPS and poly I:C prenatal immune challenges on the behavior, development and inflammatory responses in pregnant mice and their offspring.”, Brain Behav Immun, vol. 38, pp. 77-90, 2014.
, “Insulin reverses the high-fat diet-induced increase in brain Aβ and improves memory in an animal model of Alzheimer disease.”, Diabetes, vol. 63, no. 12, pp. 4291-301, 2014.
, “IVIg protects the 3xTg-AD mouse model of Alzheimer's disease from memory deficit and Aβ pathology.”, J Neuroinflammation, vol. 11, p. 54, 2014.
, “The morphological and molecular changes of brain cells exposed to direct current electric field stimulation.”, Int J Neuropsychopharmacol, vol. 18, no. 5, 2014.
, “Mutant huntingtin is present in neuronal grafts in Huntington disease patients.”, Ann Neurol, vol. 76, no. 1, pp. 31-42, 2014.
, “Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease.”, Int J Neuropsychopharmacol, vol. 18, no. 6, 2014.
,